1H-Indole-1-ethanamine, 6-bromo-2,3-dihydro-α-methyl-, (αS)- manufacturers
- VER-3323
-
- $2500.00
-
2026-05-11
- CAS:259857-99-3
- Purity:
- Supply Ability: 10g
|
| | 1H-Indole-1-ethanamine, 6-bromo-2,3-dihydro-α-methyl-, (αS)- Basic information |
| | 1H-Indole-1-ethanamine, 6-bromo-2,3-dihydro-α-methyl-, (αS)- Chemical Properties |
| Boiling point | 357.6±42.0 °C(Predicted) | | density | 1.387±0.06 g/cm3(Predicted) | | pka | 8.67±0.10(Predicted) |
| | 1H-Indole-1-ethanamine, 6-bromo-2,3-dihydro-α-methyl-, (αS)- Usage And Synthesis |
| Uses | VER-3323 is an oral active 5-HT2C agonist and belongs to the class of indoline analogs. VER-3323 reduces food intake in rats by inducing swallowing dysfunction, with no significant impact on energy expenditure generated through thermogenesis or exercise. VER-3323 can be utilized in obesity research[1]. | | IC 50 | Human 5-HT2C Receptor | | References | [1] Garfield AS, et al. Pharmacological targeting of the serotonergic system for the treatment of obesity. J Physiol. 2009 Jan 15;587(1):49-60. doi: 10.1113/jphysiol.2008.164152. Epub 2008 Nov 24. DOI:10.1113/jphysiol.2008.164152 |
| | 1H-Indole-1-ethanamine, 6-bromo-2,3-dihydro-α-methyl-, (αS)- Preparation Products And Raw materials |
|